Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag

被引:27
|
作者
Qiu, Jian-Tai
Chang, Ting- Chang
Lin, Cheng-Tao
Chen, Yi-Ming
Li, Frank Q.
Soong, Yung-Kuei
Lai, Chyong-Huey
机构
[1] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan 333, Taiwan
[2] Chang Gung Univ, Coll Med, Dept Life Sci, Tao Yuan 333, Taiwan
[3] Natl Yang Ming Univ, AIDs Prevent & Res Ctr, Taipei 112, Taiwan
[4] Vaxim Inc, Rockville, MD 20850 USA
关键词
GM-CSF; DNA vaccine; HIV-1; T-lymphocytes; immunity; COLONY-STIMULATING FACTOR; T-CELL RESPONSES; VIRUS TYPE-1 GAG; DENDRITIC CELLS; PLASMID DNA; FUSION PROTEIN; PHASE-I; EXPRESSION; IMMUNOGENICITY; ANTIGEN;
D O I
10.1016/j.vaccine.2006.07.034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent immunomodulatory cytokine. Here we generated a novel codon-optimized murine GM-CSF gene as an adjuvant. The codon-optimized GM-CSF gene significantly increased protein expression levels in all cells tested. Although injection of the wild-type GM-CSF plasmids adjuvanted HIV-1 Gag DNA vaccine induced detectable immune responses. co-administration of plasmids encoding the codon-optimized GM-CSF sequence with the DNA vaccine resulted in a strong antibody and CTL responses and a protective immune response against infection with recombinant vaccinia virus expressing HIV-1 Gag. This novel codon-optimized GM-CSF gene offers a practical molecular strategy for potentiating immune responses to vaccines as well as other immunotherapeutic strategies. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:253 / 263
页数:11
相关论文
共 31 条
  • [21] Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens
    Bolesta, E
    Gzyl, J
    Wierzbicki, A
    Kmieciak, D
    Kowalczyk, A
    Kaneko, Y
    Srinivasan, A
    Kozbor, D
    VIROLOGY, 2005, 332 (02) : 467 - 479
  • [22] Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults
    Buchbinder, Susan P.
    Grunenberg, Nicole A.
    Sanchez, Brittany J.
    Seaton, Kelly E.
    Ferrari, Guido
    Moody, M. Anthony
    Frahm, Nicole
    Montefiori, David C.
    Hay, Christine M.
    Goepfert, Paul A.
    Baden, Lindsey R.
    Robinson, Harriet L.
    Yu, Xuesong
    Gilbert, Peter B.
    McElrath, M. Juliana
    Huang, Yunda
    Tomaras, Georgia D.
    PLOS ONE, 2017, 12 (07):
  • [23] Coadministration of chicken GM-CSF with a DNA vaccine expressing infectious bronchitis virus (IBV) S1 glycoprotein enhances the specific immune response and protects against IBV infection
    Tan, Bing
    Wang, Hongning
    Shang, Liqing
    Yang, Tai
    ARCHIVES OF VIROLOGY, 2009, 154 (07) : 1117 - 1124
  • [24] Protective efficacy and immune responses induced by a DNA vaccine encoding codon-optimized PPA1 against Photobacterium damselae subsp. piscicida in Japanese flounder
    Kato, Goshi
    Yamashita, Kozue
    Kondo, Hidehiro
    Hirono, Ikuo
    VACCINE, 2015, 33 (08) : 1040 - 1045
  • [25] Inhibition of HIV-1 gene expression by novel DNA enzymes targeted to cleave HIV-1 TAR RNA: Potential effectiveness against all HIV-1 isolates
    Chakraborti, S
    Banerjea, AC
    MOLECULAR THERAPY, 2003, 7 (06) : 817 - 826
  • [26] Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1
    Kazzaz, J
    Neidleman, J
    Singh, M
    Ott, G
    O'Hagan, DT
    JOURNAL OF CONTROLLED RELEASE, 2000, 67 (2-3) : 347 - 356
  • [27] Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: Different effects on cellular and humoral immunity
    Ganguly, Sumita
    Liu, Jinyan
    Pillai, Vinod B.
    Mittler, Robert S.
    Amara, Rama Rao
    VACCINE, 2010, 28 (05) : 1300 - 1309
  • [28] A Novel Tuberculosis DNA Vaccine in an HIV-1 p24 Protein Backbone Confers Protection against Mycobacterium tuberculosis and Simultaneously Elicits Robust Humoral and Cellular Responses to HIV-1
    Li, Xiaoman
    Xu, Wei
    Xiong, Sidong
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (05) : 723 - 730
  • [29] Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8+ responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera
    Chikhlikar, P
    de Arruda, LB
    Agrawal, S
    Byrne, B
    Guggino, W
    August, JT
    Marques, ETA
    VIROLOGY, 2004, 323 (02) : 220 - 232
  • [30] A novel self-assembled nanoparticle vaccine with HIV-1 Tat49-57/HPV16 E749-57 fusion peptide and GM-CSF DNA elicits potent and prolonged CD8+ T cell-dependent anti-tumor immunity in mice
    Tang, Jun
    Yin, Rui
    Tian, Yi
    Huang, Zeming
    Shi, Jinglei
    Fu, Xiaolan
    Wang, Li
    Wu, Yuzhang
    Hao, Fei
    Ni, Bing
    VACCINE, 2012, 30 (06) : 1071 - 1082